ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

New Report On Survival Data Available From NCI

July 25, 1975

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001

House Appropriations Committee Approves $1.221 Bil. Budget For NCI In Fiscal 1986; NIH Gets 45.247 Bil.

October 4, 1985

DeVita Heads U.S. Board Of CCCR

August 4, 1989